 |
Tularemia |
|
| Medical
Response |
|
|
|
Tularemia presents as a systemic febrile illness and
diagnosis may be made by culture of body fluid or serologic tests. Tularemia is
easily treatable with antibiotics as long as victims receive treatment quickly.
If a patient is not treated, the fatality rate can exceed 30 percent.
Isolation is not recommended for tularemia patients because it is not
transmitted from person to person.
It is a United States Public Health Service requirement that all suspected tularemia cases
be reported to
state and local health departments and the diagnosis confirmed by the Centers for
Disease Control and Prevention (CDC).
- Tärnvik A, and Chu, MC. "New Approaches to diagnosis and therapy of Tularemia."
Annals of the New York Academy of Science 1105(2007, June):
378-404. Concludes that the clinical handling of tularemia is currently
facilitated by new achievements in molecular diagnostics and, at least with
regard to type B tularemia, by the introduction of quinolones for therapy.
- Medical
Treatment and Response to Suspected Tularemia: Information for Healthcare
Providers During Biologic Emergencies. New York City Department of
Health, Bureau of Communicable Disease, (2000, July). Provides information on epidemiology, diagnosis, and treatment with a
bioterrorism perspective.
- Evans M.E., and A.M. Friedlander. "Tularemia." Textbook of Military Medicine: Medical Aspects of
Chemical and Biological Warfare (1997), 56 KB
PDF,
10 pages. Provides a
thorough medical description of the disease including epidemiology,
pathogenesis, symptoms, diagnosis, and treatment.
- Clinical Pathway: Pneumonic Tularemia. University of
Minnesota (UM), Center
for Infectious Disease Research and Policy (CIDRAP), (2002), 243 KB PDF,
3 pages. Provides step-by-step procedures for patient
evaluation and treatment.
|
|
|
|
Back to Top
